With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

This will allow Sandoz’s Humira biosimilar ... adalimumab can help to expand access for those who need it most and give patients and doctors confidence in their chosen treatment option.

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of ... for years with its TNF inhibitor Humira (adalimumab), which is now ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Everyone knows what a bad speech sounds like. But very few know how to write good a one — and even fewer have what it takes ...

Stocks offer 9%-10% annualized returns, promising substantial long-term wealth growth. Different investment methods like individual stocks or index funds cater to various investor commitments and ...

Excluding Humira, total revenue grew 18% year-over-year, with the neuroscience and oncology segments leading the growth. An American pharmaceutical company, Bristol-Myers Squibb Company (NYSE ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Yes, they do. So you can give your loved ones the gift of choice with a Microsoft or Xbox gift card! Choosing one of these gift cards gives the recipient the chance to get devices, games ...